
Relmada Therapeutics (NASDAQ:RLMD) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement.
Analysts estimate that Relmada Therapeutics will report an earnings per share (EPS) of $-1.83.